Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
GHK-Cu half-life: 2-4 hours in circulation. Rapid clearance means consistent dosing is essential—skip days significantly delays results. Daily topical or 2-3x weekly injectable maintains effective stimulus.
Understanding GHK Half-Life
Half-life is the time required for 50% of a substance to be cleared from circulation. GHK-Cu has a half-life of approximately 2-4 hours, meaning half of an injected dose is cleared from your bloodstream within that timeframe. This rapid clearance reflects the body's normal metabolism of peptides—they're broken down into amino acids and cleared by kidneys. The short half-life is actually beneficial from a safety perspective (no systemic accumulation) but has important implications for dosing strategy.
Why Half-Life Matters for GHK Dosing
With 2-4 hour half-life, a single injection provides active GHK-Cu stimulus for only a few hours. Continuing systemic benefits requires regular re-dosing. This is why injectable protocols recommend 2-3x weekly dosing—spacing injections 2-3 days apart maintains relatively constant low-level stimulus without gaps. Topical GHK-Cu application creates local high concentration that persists longer than injected systemically, partly explaining why topical application requirement is simply daily (once or twice) rather than injectable's 2-3x weekly frequency.
Topical vs. Injectable Half-Life Implications
Topical: GHK-Cu in serum remains on/in skin longer than injectable remains in circulation. Local skin concentration persists 12+ hours, justifying daily application as sufficient. The peptide isn't rapidly systemically cleared; it acts locally on fibroblasts for extended duration. Injectable: Systemic circulation clears the peptide within 4-8 hours (by 2 half-lives, 75-95% cleared). To maintain continuous stimulus, injection frequency of 2-3x weekly is necessary.
Metabolism and Clearance
GHK-Cu is metabolized like any peptide: broken down into component amino acids (glycine, histidine, lysine) plus copper. The copper is rebound to copper-binding proteins and incorporated into normal copper metabolism. The amino acids enter the amino acid pool for protein synthesis or energy use. This process is completely normal and safe—no accumulation occurs even with chronic use.
Consistency Implications of Short Half-Life
Because GHK-Cu clears so rapidly, skipping doses creates gaps in collagen-stimulation signal. Missing one day of topical application or one injection doesn't dramatically impair results, but chronic missed doses significantly extends timeline and reduces final outcomes. This is why consistency is emphasized so heavily—the short half-life makes regular dosing non-negotiable for efficacy.
Dosing Strategy Based on Half-Life
For maximum efficacy: Daily topical or maintain as close to continuous low-level stimulus as practical. For practical protocol: Topical daily provides adequate stimulus window. Injectable 2-3x weekly maintains effective stimulus despite rapid clearance. For flexibility: Topical every other day extends timeline but remains effective (reduces peak stimulus but increases consistency reliability). Injectable 1x weekly is suboptimal but better than sporadic.
Comparison: GHK Half-Life vs. Other Compounds
| Compound | Half-Life | Dosing Frequency |
|---|---|---|
| GHK-Cu (injectable) | 2-4 hours | 2-3x weekly |
| TB-500 | 8-12 hours | 1-2x weekly |
| Botox | Weeks (permanent effect) | Every 3-4 months |
| Retinol (topical) | Local, slow clearance | 3-5x weekly |
| Vitamin C (topical) | Local, persists 24+ hours | Daily |
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →FAQ: GHK Half-Life
Summary
GHK-Cu's 2-4 hour half-life explains its dosing requirements: topical daily (local persistence is longer), injectable 2-3x weekly (systemic clearance is rapid). Short half-life is actually beneficial for safety but requires consistent dosing for efficacy. Skipping doses extends timeline and reduces results; maintaining protocol delivers optimal collagen-building stimulus.